At A Glance - etp.tst-web.illumina.com · At A Glance We serve customers in a broad range of...
Transcript of At A Glance - etp.tst-web.illumina.com · At A Glance We serve customers in a broad range of...
At A Glance
We serve customers in a broad range of research, clinical, and applied markets, including:
Who we serve
Who we are
Quick facts
Francis deSouzaPresident & CEO
$2.75 billion (2017)Annual revenue
1998Year founded
~7,000+Number of employees
San Diego, California, USAHeadquarters
OncologyReproductive
healthMolecular
& cell biologyAgriculture
We enable the adoption of genomic solutions in settings such as:
Universities and academic
research centers
Genome centers Hospitals
Government agencies
Pharmaceutical companies
Biotechnology companies
Consumer genetics
companies
As a global leader in DNA sequencing and microarray-based solutions, we are dedicated to improving human health by unlocking the power of the genome. Our technology is responsible for generating more than 90% of the world’s sequencing data.1
Genetic disease Microbiology
Where we operate
United StatesSan Diego (Headquarters)Carroll Park
Foster City
Madison
BrazilSão Paulo
United KingdomChesterford FulbournCambridge
FranceÉvry
NetherlandsEindhoven
ChinaBeijing
Shanghai
JapanTokyo
Osaka
Singapore
AustraliaMelbourne
Korea Seoul
For Research Use Only. Not for use in diagnostic procedures.
References1. Data calculations on �le. Illumina, Inc., 20172. Wetterstrand KA. DNA Sequencing Costs: Data from the NHGRI Genome Sequencing Program (GSP). Available at: www.genome.gov/sequencingcosts3. Illumina, Inc. HiSeq X™ Ten: $1,000 Genome and Extreme Throughput for Population-Scale Sequencing.
Available at: https://www.illumina.com/documents/products/datasheets/datasheet-hiseq-x-ten.pdf
© 2018 Illumina, Inc. All rights reserved. PUB 070-2017-022 QB 5893
Making breakthroughs possibleIllumina has developed one of the world’s most comprehensive genomics portfolio of integrated systems, consumables, and analysis tools. With each technological breakthrough, we help scientists better understand genetic variation at all levels of complexity.
$100 million2
$1,0003
2001
2017
Cost of sequencing, per human whole genome
Since 2001, the cost of DNA sequencing has dropped more than 100,000x from $100 million per human genome to $1,000 today. Discoveries that were unimaginable a few years ago are now becoming routine.
A recognized leader
World’s Most Innovative Companies List
Forbes 2014 (#36)Forbes 2015 (#35)Forbes 2016 (#24)Forbes 2017 (#18)
10 Breakthrough Technologies 2013
MIT Technology Review 2013
Top 50 Disruptive Companies MIT Technology
Review 2010, 2013
Fastest-Growing Tech Companies Forbes 2007, 2009, 2010
Fortune 2016
50 Smartest CompaniesMIT Technology Review
2014 (#1), 2015 (#3), 2016 (#3), 2017 (#22)
10 Most InnovativeBiotech Companies
Fast Company 2016, 2017
Sequencing systems
Array scanners
iScan™ System
Genotyping, CNV analysis, DNA methylation, and gene expression pro�ling.
HiSeq X™ Ten
High-throughput for population-scalewhole-genome sequencing.
HiSeq™ 4000
Production-scale instruments for genome sequencing, exome sequencing, and transcriptome sequencing.
NextSeq™ 550
Desktop sequencers for genome sequencing, exome sequencing, transcriptome sequencing and cytogenomic array scanning. Series includes NextSeq 550 and NextSeq 550Dx platforms.*
MiSeq™
Desktop sequencer for targeted and small-genome sequencing. Series includes MiSeq, MiSeqDx® platforms.†
MiniSeq™
Desktop sequencer for targeted DNA and targeted RNA sequencing.
NovaSeq™ 6000
High-throughput for any species, application, or scale of sequencing project.
iSeq™
Benchtop sequencer for targeted gene sequencing, direct amplicon sequencing, and small-genome sequencing.
*NextSeq 550Dx is FDA-regulated and CE-marked for in vitro diagnostic use.†MiSeqDx is a 510(k) cleared, CE-marked instrument for in vitro diagnostic use. MiSeq FGx is for forensic genomics applications.